MLN9708 and Dexamethasone for High-Risk Smoldering Multiple Myeloma

NCT01660997 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

NIH

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: MLN9708
DRUG: Dexamethasone

Sponsor

National Cancer Institute (NCI)